Highlights

  • IPX shares has gained 8.375 to UAD 5.18 during the Trading session  on 7 May 2026
  • IperionX shares gained nearly 30% over the past month
  • The company transitioned its Virginia titanium operations to 24/7 production during the March 2026 quarter

 

Shares of IperionX Ltd (ASX:IPX) have drawn renewed investor attention after posting strong gains over the past month, supported by operational progress, increased U.S. government engagement, and continued expansion across its titanium production platform.

The company’s stock traded at AUD 5.18 on May 7, rising 8.37% during the trading session and extending its one-month gain to approximately 29.3%. The move significantly outpaced the broader S&Amp;P/ASX 300 Metals & Mining index, which gained 3.11% on the same day.

Adding to market interest, Brokers have maintained speculative buy rating on the stock, reflecting continued optimism around IperionX’s commercialization pathway and strategic positioning within the U.S. titanium Supply chain.

Production Ramp-Up Marks Operational Milestone

A major focus of the company’s March 2026 Quarterly Report was the operational transition at its Virginia titanium facilities. During the quarter, IperionX shifted into continuous 24/7 production, marking a key step from commissioning activities toward scaled commercial operations.

The company confirmed that all HAMR™ titanium powder production systems have now been commissioned and are entering ramp-up mode. Management continues to target annualized run-rate production of approximately 200 tonnes per annum of titanium powder by the end of calendar year 2026.

Production growth was already visible during the quarter. Titanium powder output reached approximately 4.2 metric tons in March alone, representing an annualized production pace of roughly 50 tonnes. While management described this as an early-stage ramp rate, the company expects throughput to improve as Manufacturing shifts toward larger-Volume powder products and expanded powder-to-part manufacturing.

The operational transition is significant because it demonstrates that IperionX is moving beyond development-stage activities into scalable manufacturing execution. Investors have closely monitored this milestone given the company’s broader ambition to establish a vertically integrated titanium supply chain in the United States.

GenX Platform Development Adds Long-Term Focus

In addition to current production ramp-up activities, IperionX continued advancing its next-generation GenX™ continuous HAMR™ production platform.

The GenX™ system is designed to improve production Economics by lowering operating costs, increasing throughput, and improving Capital efficiency compared with existing batch-processing systems. While still under development, the technology represents an important component of the company’s long-term manufacturing strategy.

Management has consistently emphasized that future competitiveness in titanium production will depend not only on output scale but also on production efficiency and cost advantages. The GenX™ initiative appears aligned with that strategy.

Expansion Across Titanium Product Manufacturing

IperionX also reported progress in titanium product manufacturing capabilities during the quarter.

The company continued scaling its powder metallurgy operations, including optimization of its 100-ton uniaxial press and commissioning of a cold isostatic press for larger-format titanium components. Defense-related titanium fastener production also moved toward continuous 24/7 operations.

Another major development involved installation of a six-axis 300-ton SACMI powder metallurgy press. According to the company, the advanced system is expected to support more complex titanium component manufacturing while enabling higher-rate production and improved repeatability.

Commissioning of the SACMI press is scheduled for the June quarter and is expected to support customer engagements involving higher-volume or more technically demanding titanium parts.

The company is also increasing sintering capacity through additional HSPT™ furnaces, which are expected to help reduce existing production bottlenecks and accelerate customer qualification timelines.

These manufacturing upgrades suggest that IperionX is preparing for broader commercial engagement across multiple industrial sectors rather than relying solely on raw titanium powder sales.

Customer Engagement Continues to Expand

Commercial activity also accelerated during the quarter, particularly across aerospace, defense, automotive, industrial, and consumer electronics markets.

Management stated that current production activity remains concentrated on prototype development, qualification testing, and low-rate initial production. This aligns with the staged commercialization process typically seen in advanced materials and aerospace supply chains, where qualification timelines can extend over multiple quarters before large-scale purchase orders emerge.

One notable area of progress involved spherical titanium powders for additive manufacturing applications in consumer electronics. Qualification and testing work accelerated during the quarter, potentially opening access to a significant future market opportunity.

The company also reported materially higher customer engagement across aerospace and defense sectors. Management attributed this trend partly to growing interest in supply-chain resilience and increased U.S. efforts to reduce dependence on imported titanium products.

U.S. Government Support Remains a Major Strategic Advantage

One of the most important themes surrounding IperionX remains its relationship with the U.S. government and its positioning within domestic critical mineral and advanced manufacturing initiatives.

During the quarter, the company continued advancing its government-supported 1,400-tonne-per-annum titanium expansion program. This includes the fully obligated US$47.1 million Industrial Base Analysis and Sustainment (IBAS) award designed to support development of an integrated domestic titanium supply chain.

Government support also included approximately 290 metric tons of titanium scrap transferred to the company at no cost. According to management, this feedstock volume represents roughly 1.5 years of titanium supply requirements.

In addition, IperionX continues to progress under a Small Business Innovation Research (SBIR) Phase III Indefinite Delivery Indefinite Quantity (IDIQ) contract that could potentially reach up to US$99 million through future task orders.

The company’s alignment with U.S. strategic supply-chain priorities has become increasingly important as Western governments seek to strengthen domestic production capabilities for critical minerals and advanced defense-related materials.

Titan Project Progress Adds Longer-Term Optionality

Beyond current manufacturing operations, IperionX continued progressing the Definitive Feasibility Study for its Titan Critical Minerals Project.

The project remains fully permitted and strategically important because of its exposure not only to titanium but also to rare earth minerals and zircon. The deposit includes heavy rare earth elements such as dysprosium, terbium, and yttrium, all of which are increasingly important in advanced manufacturing and defense technologies.

Management stated that the feasibility study remains on track for completion in mid-2026. The company also confirmed ongoing discussions with the U.S. government regarding potential funding pathways to accelerate development once the study is finalized.

Financial Position and Cash Outlook

IperionX ended the March 2026 quarter with a cash balance of US$48.2 million.

The company noted that quarterly cash usage included approximately US$4.8 million in non-run-rate and timing-related items, alongside continued Investment in production ramp-up activities, Research and Development, and manufacturing scale-up initiatives.

In addition to reported cash reserves, the company had approximately US$42.1 million in remaining obligated reimbursable U.S. government funding as of March 31, 2026. This figure included US$3.5 million in eligible expenses already incurred but awaiting reimbursement approval.

Management expects to end fiscal year 2026 with cash reserves between US$36 million and US$40 million based on current operating plans and anticipated reimbursement timing.

Conclusion

IperionX’s latest quarterly update highlighted a company transitioning steadily toward scaled commercial operations while strengthening its role within the U.S. critical minerals and advanced manufacturing ecosystem. The shift to continuous production, expanded manufacturing capability, growing customer engagement, and ongoing government support appear to be key drivers behind recent investor interest in the stock.